These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3488420)

  • 41. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The receptor binding study in vivo].
    Inoue O; Kobayashi K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):215-25. PubMed ID: 7975926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain incorporation of [1-11C]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography.
    Chang MC; Arai T; Freed LM; Wakabayashi S; Channing MA; Dunn BB; Der MG; Bell JM; Sasaki T; Herscovitch P; Eckelman WC; Rapoport SI
    Brain Res; 1997 Apr; 755(1):74-83. PubMed ID: 9163542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
    Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR
    J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
    Hall H; Lundkvist C; Halldin C; Farde L; Pike VW; McCarron JA; Fletcher A; Cliffe IA; Barf T; Wikström H; Sedvall G
    Brain Res; 1997 Jan; 745(1-2):96-108. PubMed ID: 9037397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.
    Gunn RN; Lammertsma AA; Hume SP; Cunningham VJ
    Neuroimage; 1997 Nov; 6(4):279-87. PubMed ID: 9417971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography.
    Mukherjee J; Yang ZY; Lew R; Brown T; Kronmal S; Cooper MD; Seiden LS
    Synapse; 1997 Sep; 27(1):1-13. PubMed ID: 9268060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.
    Halldin C; Farde L; Lundkvist C; Ginovart N; Nakashima Y; Karlsson P; Swahn CG
    Synapse; 1996 Apr; 22(4):386-90. PubMed ID: 8867033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imaging of neurotransmitter receptors in the living human brain.
    Sedvall G; Farde L; Persson A; Wiesel FA
    Arch Gen Psychiatry; 1986 Oct; 43(10):995-1005. PubMed ID: 3019270
    [No Abstract]   [Full Text] [Related]  

  • 52. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiolabeled ligands for imaging the muscarinic-cholinergic receptors of the heart and brain.
    Knapp FF; McPherson DW; Luo H; Zeeburg B
    Anticancer Res; 1997; 17(3B):1559-72. PubMed ID: 9179195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ligands for imaging opioid receptors in conscious humans by positron emission tomography (PET).
    Newman A; Channing M; Finn R; Dunn B; Simpson N; Carson R; Ostrowski N; Cohen R; Burke T; Larson S
    NIDA Res Monogr; 1988; 90():117-21. PubMed ID: 2855850
    [No Abstract]   [Full Text] [Related]  

  • 55. Radiolabeled ligands expand PET exploration of numerous normal, abnormal brain functions.
    Riesenberg D
    JAMA; 1986 Aug 22-29; 256(8):969-70. PubMed ID: 3488420
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.